Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 21, 2021 - Issue 1
Submit an article Journal homepage
2,138
Views
4
CrossRef citations to date
0
Altmetric
Original research

A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.

Vakaramoko Diabya College of Pharmacy, HPNP 3317, University of Florida, Gainesville, FL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6251-0773View further author information
ORCID Icon,
Reem D. Almutairib Department of Pharmaceutical Business and Administration Sciences, MCPHS University, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-4391-5345View further author information
ORCID Icon,
Ziyan Chena College of Pharmacy, HPNP 3317, University of Florida, Gainesville, FL, USAView further author information
,
Richard K. Moussac Théorie Économique, Modélisation et Applications (ThEMA), Université de Cergy-Pontoise, France and Ecole Nationale Supérieure de Statistiques et d’Economie Appliquée (ENSEA)ORCID Iconhttps://orcid.org/0000-0003-0046-1053View further author information
ORCID Icon &
Abdrahmane Berthed Northwest Territories Government, Yellowknife, CanadaView further author information
Pages 159-168 | Received 31 Aug 2020, Accepted 12 Nov 2020, Published online: 08 Dec 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shuohan Huang, Zihan Guo, Mengmeng Wang, Youjun She, Xuan Ye, Qing Zhai, Jiyong Liu & Qiong Du. (2023) Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system. Expert Opinion on Drug Safety 22:2, pages 175-181.
Read now

Articles from other publishers (3)

Min Luo, Bin Wu, Yuwen Li & Fengbo Wu. (2022) An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19. International Journal of Clinical Pharmacy 44:5, pages 1179-1187.
Crossref
Ying Zhao, Jingru Zhang, Kai Zheng, Sydney Thai, Ross J. SimpsonJr.Jr., Alan C. Kinlaw, Yang Xu, Jingkai Wei, Xiangli Cui, John B Buse, Til Stürmer & Tiansheng Wang. (2022) Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS). Drugs - Real World Outcomes 9:2, pages 231-241.
Crossref
Gulnara I. SyraevaS.A. MishinovaAlexey S. KolbinE.O. Eremenko. (2021) Safety profile assessment of drug products used for the pathogenetic treatment of COVID19. Clinical Microbiology and Antimicrobial Chemotherapy 23:3, pages 314-329.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.